Law360 mentions Doug Baldridge, Lisa Jose Fales, Danielle Foley and Sarah Choi in the article "AstraZeneca Can't End Nexium Pay-For-Delay Trial" posted on November 24, 2014.
The plaintiffs claim AstraZeneca PLC conspired with two generic drug makers to game the patent system in order to overcharge consumers for a heartburn treatment. On Monday, a Massachusetts federal judge refused to allow AstraZeneca PLC and Ranbaxy Inc. to end a pay-for-delay trial over the heartburn drug Nexium, saying the case should go before a jury. Teva Pharmaceutical Industries Ltd. opted to settle with the plaintiffs.